News & Events
Company updates, exhibitions and technical insights from Safheal.
Sales feedback from Thai market partners shows that Safheal respiratory combo rapid tests have entered the top three among comparable products in local channel sales.
Read Details
Safheal has completed development and marketing documentation for the Feline Blood Type A/B/AB Rapid Test Kit, expanding its in-clinic veterinary rapid diagnostic portfolio.
Read Details
Safheal has completed development and documentation work for the Feline Calprotectin Semi-Quantitative Rapid Test, strengthening its rapid diagnostic portfolio for professional customers.
Read Details
Safheal has completed development and documentation work for the Human Pancreatic Elastase Rapid Test, strengthening its rapid diagnostic portfolio for professional customers.
Read Details
Safheal has completed development and documentation work for the Human ABO/RhD Blood Type Rapid Test, strengthening its rapid diagnostic portfolio for professional customers.
Read Details
Safheal sends Dragon Boat Festival greetings to global partners and shares current industry signals in rapid diagnostics, animal health and quality-system trust building.
Read Details
WHO work on selection, access and use of IVDs is moving rapid testing beyond a single-product discussion toward primary-care networks, supply stability and registration-ready evidence.
Read Details
WOAH frames antimicrobial resistance as a shared animal-health and public-health challenge. Rapid tests do not replace veterinarians, but they provide earlier evidence for isolation, retesting and treatment decisions.
Read Details
FDA’s QMSR final rule brings medical-device quality-system expectations closer to ISO 13485:2016. For IVD buyers, batch records, stability, validation evidence and change control are now supplier-screening priorities.
Read Details
Safheal showcased pet and animal diagnostic solutions at WESAVC 2026, presenting rapid tests, PCR, chemiluminescence and IVD raw material capabilities.
Read More
Safheal (Hangzhou) showcased rapid test and molecular diagnostic solutions for human, pet and livestock applications at 2026 Animal Health China in Shanghai.
Read More
Safheal attended CACLP 2026 in Xiamen, presenting rapid diagnostic products for human, pet and livestock applications.
Read More
Safheal presented veterinary rapid tests, POCT instruments and animal health diagnostic solutions at Pet Fair Asia 2025 in Shanghai.
Read More
Safheal confirmed participation in WHX Nairobi 2025, bringing animal rapid test solutions to East African healthcare and veterinary markets.
Read More
Safheal will bring its veterinary rapid test portfolio to Vet Expo Australia 2025, supporting market expansion in Oceania.
Read More
Safheal confirmed participation in the 92nd China International Medical Equipment Fair, showcasing IVD rapid tests and POCT solutions.
Read More
Safheal will attend JPE Jakarta International Pet Expo 2025 to accelerate its animal health diagnostics expansion across Southeast Asia.
Read More
Safheal will join Petfair Vietnam 2025 in Ho Chi Minh City to deepen engagement with Southeast Asian veterinary and pet healthcare customers.
Read More
Safheal will present veterinary rapid diagnostics, POCT applications and channel cooperation solutions at custom booth F117 during WESAVC 2025 Xiamen.
Read More
Safheal attended the 91st CMEF in Shanghai, presenting rapid test solutions for human and animal health.
Read More
Safheal exhibited at MEDLAB Middle East 2025 in Dubai, presenting IVD rapid tests and OEM/ODM manufacturing capabilities.
Read More
Safheal COVID-19 antigen rapid test obtained access qualification from Germany BfArM, reflecting alignment with strict European quality requirements.
Read More
The Delta variant caused renewed outbreaks in several countries, highlighting the importance of vaccination, surveillance and rapid testing capacity.
Read More
Safheal summarizes practical troubleshooting experience for sample pads, chromatography speed, false positives and drying-related instability.
Read More
Large-scale testing helped identify potential transmission chains while creating challenges in sampling, throughput, logistics and cost control.
Read More